A citation-based method for searching scientific literature

E Claes, G Evers-Kiebooms, L Denayer, M Decruyenaere, A Boogaerts, K Philippe, E Legius. J Genet Couns 2005
Times Cited: 49







List of co-cited articles
353 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
195
26

Psychological impact of genetic testing in women from high-risk breast cancer families.
B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
93
22

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
228
20

Genetic susceptibility testing from a stress and coping perspective.
Holly C Gooding, Kurt Organista, Jeffrey Burack, Barbara Bowles Biesecker. Soc Sci Med 2006
66
18

Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
241
18

Psychological impact of receiving a BRCA1/BRCA2 test result.
L Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, A M van den Ouweland,[...]. Am J Med Genet 2001
116
18

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
123
18

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
18

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
18


Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Ellen R Gritz, Susan K Peterson, Sally W Vernon, Salma K Marani, Walter F Baile, Beatty G Watts, Christopher I Amos, Marsha L Frazier, Patrick M Lynch. J Clin Oncol 2005
88
16



Motivations and psychosocial impact of genetic testing for HNPCC.
M J Esplen, L Madlensky, K Butler, W McKinnon, B Bapat, J Wong, M Aronson, S Gallinger. Am J Med Genet 2001
74
14

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
938
14

Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.
Erna Claes, Lieve Denayer, Gerry Evers-Kiebooms, Andrea Boogaerts, Eric Legius. Patient Educ Couns 2004
63
14

Genetic testing: psychological aspects and implications.
Caryn Lerman, Robert T Croyle, Kenneth P Tercyak, Heidi Hamann. J Consult Clin Psychol 2002
178
14

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
14

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
129
14

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
12

Toward a biopsychosocial model for 21st-century genetics.
John S Rolland, Janet K Williams. Fam Process 2005
127
12



Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
12

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
12

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
12

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
243
12


Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families.
J C Coyne, N R Benazon, C G Gaba, K Calzone, B L Weber. J Consult Clin Psychol 2000
92
12


Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
Amy Østertun Geirdal, Jon G Reichelt, Alv A Dahl, Ketil Heimdal, Lovise Maehle, Astrid Stormorken, Pål Møller. Fam Cancer 2005
30
20

Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
B Meiser, V Collins, R Warren, C Gaff, D J B St John, M-A Young, K Harrop, J Brown, J Halliday. Clin Genet 2004
62
12

The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation.
Anita Yeomans Kinney, Lindsey E Bloor, Diptasri Mandal, Sara Ellis Simonsen, Bonnie Jeanne Baty, Richard Holubkov, Kate Seggar, Susan Neuhausen, Ken Smith. Cancer 2005
31
19

A literature review of the psychological impact of genetic testing on breast cancer patients.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Margreet G E M Ausems. Patient Educ Couns 2006
63
12

Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer.
Jacqueline Lim, Mariette Macluran, Melanie Price, Barbara Bennett, Phyllis Butow. J Genet Couns 2004
36
16

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
175
12

The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.
Iris van Oostrom, Hanne Meijers-Heijboer, Hugo J Duivenvoorden, Annette H J T Bröcker-Vriends, Christi J van Asperen, Rolf H Sijmons, Caroline Seynaeve, Arthur R Van Gool, Jan G M Klijn, Aad Tibben. Psychooncology 2007
35
17


Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
68
12

BRCA1 in the family: a case description of the psychological implications.
A C DudokdeWit, A Tibben, P G Frets, E J Meijers-Heijboer, P Devilee, J G Klijn, J C Oosterwijk, M F Niermeijer. Am J Med Genet 1997
67
10

Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test.
Erna Claes, Lieve Denayer, Gerry Evers-Kiebooms, Andrea Boogaerts, Kristien Philippe, Sabine Tejpar, Koen Devriendt, Eric Legius. Genet Test 2005
51
10

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P Tercyak, Danielle Hanna, Claudine Isaacs,[...]. Am J Med Genet 2002
156
10

Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective.
M Decruyenaere, G Evers-Kiebooms, M Welkenhuysen, L Denayer, E Claes. Psychooncology 2000
62
10

Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Michael Andrykowski, Deborah Toppmeyer, Judy Much, James Dermody, Monica Marvin, Jill Baran, Marvin Schwalb. Psychooncology 2005
60
10

Family communication about genetic risk: the little that is known.
Brenda J Wilson, Karen Forrest, Edwin R van Teijlingen, Lorna McKee, Neva Haites, Eric Matthews, Sheila A Simpson. Community Genet 2004
115
10


Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
Mariëlle S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Am J Med Genet A 2004
49
10

Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
Brita Arver, Aina Haegermark, Ulla Platten, Annika Lindblom, Yvonne Brandberg. Fam Cancer 2004
46
10

Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
Iris van Oostrom, Hanne Meijers-Heijboer, Hugo J Duivenvoorden, Annette H J T Bröcker-Vriends, Christi J van Asperen, Rolf H Sijmons, Caroline Seynaeve, Arthur R Van Gool, Jan G M Klijn, Aad Tibben. Eur J Cancer 2007
25
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.